Know Cancer

or
forgot password

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia


Phase 4
20 Years
80 Years
Not Enrolling
Both
Oral Leukoplakia

Thank you

Trial Information

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia


Photodynamic therapy for oral leukoplakia and erythroleukoplakia


Inclusion Criteria:



- patients with leukoplakia or erythroleukoplakia

Exclusion Criteria:

- oral cancers

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

End of 8 treatments

Principal Investigator

Chun-Pin Chiang, DMSc

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Taiwan University Hospital

Authority:

Taiwan: Department of Health

Study ID:

9361700753

NCT ID:

NCT00155337

Start Date:

August 2004

Completion Date:

December 2007

Related Keywords:

  • Oral Leukoplakia
  • leukoplakia
  • erythroleukoplakia
  • photodynamic therapy
  • Leukoplakia
  • Leukoplakia, Oral

Name

Location